Biopharm, L.l.c. - Net Worth and Insider Trading
Biopharm, L.l.c. Net Worth
The estimated net worth of Biopharm, L.l.c. is at least $21 Million dollars as of 2025-05-04. Biopharm, L.l.c. is the 13(d) group member, owns > 10% of Emergent BioSolutions Inc and owns about 4,065,043 shares of Emergent BioSolutions Inc (EBS) stock worth over $21 Million. Details can be seen in Biopharm, L.l.c.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Biopharm, L.l.c. has not made any transactions after 2006-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Biopharm, L.l.c.
Biopharm, L.l.c. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Biopharm, L.l.c. owns 1 companies in total, including Emergent BioSolutions Inc (EBS) .
Click here to see the complete history of Biopharm, L.l.c.’s form 4 insider trades.
Insider Ownership Summary of Biopharm, L.l.c.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2009-05-29 | 10 percent owner |
Biopharm, L.l.c. Latest Holdings Summary
Biopharm, L.l.c. currently owns a total of 1 stock. Biopharm, L.l.c. owns 4,065,043 shares of Emergent BioSolutions Inc (EBS) as of November 14, 2006, with a value of $21 Million.
Latest Holdings of Biopharm, L.l.c.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2006-11-14 | 4,065,043 | 5.14 | 20,894,321 |
Holding Weightings of Biopharm, L.l.c.
Biopharm, L.l.c. Form 4 Trading Tracker
According to the SEC Form 4 filings, Biopharm, L.l.c. has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 0 shares on November 14, 2006, which brought Biopharm, L.l.c. around $0.
Insider Trading History of Biopharm, L.l.c.
- 1
Biopharm, L.l.c. Trading Performance
Biopharm, L.l.c. Ownership Network
Ownership Network List of Biopharm, L.l.c.
Ownership Network Relation of Biopharm, L.l.c.
Biopharm, L.l.c. Owned Company Details
What does Emergent BioSolutions Inc do?
Who are the key executives at Emergent BioSolutions Inc?
Biopharm, L.l.c. is the 10 percent owner of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .
Emergent BioSolutions Inc (EBS) Insider Trades Summary
Over the past 18 months, Biopharm, L.l.c. made no insider transaction in Emergent BioSolutions Inc (EBS). Other recent insider transactions involving Emergent BioSolutions Inc (EBS) include a net sale of 22,919 shares made by Kathryn C Zoon , a net sale of 35,000 shares made by Neal Franklin Fowler , and a net sale of 25,000 shares made by Donald W Degolyer .
In summary, during the past 3 months, insiders sold 45,000 shares of Emergent BioSolutions Inc (EBS) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 97,206 shares of Emergent BioSolutions Inc (EBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 97,206 shares.
Emergent BioSolutions Inc (EBS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Emergent BioSolutions Inc Insider Transactions
Biopharm, L.l.c. Mailing Address
Above is the net worth, insider trading, and ownership report for Biopharm, L.l.c.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Biopharm, L.l.c.'s mailing address is: Potomac Md 20854.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
